(3.23.92.186)
Users online: 22670     
Ijournet
Email id
 

Asian Journal of Pharmaceutical Analysis
Year : 2023, Volume : 13, Issue : 1
First page : ( 13) Last page : ( 20)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.52711/2231-5675.2023.00003

Simultaneous Estimation of Ampicillin and Sulbactam in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry

Reddy Srinivasa, Thomas Licto, Venkatesan P, Mukhopadhyay Arindam*, Thangam Saral

Norwich Clinical Services, Bangalore, Karnataka, India

*Corresponding Author E-mail: arindam.mukhopadhyay@norwichclinical.com

Online Published on 03 October, 2023.

Abstract

A LCMS/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma was described. After protein precipitation using 2mL of acetonitrile, 250µL of supernatant was mixed with 1.000 mL of 0.1% Acetic Acid in Milli-Q-water. 10µL was injected to a Biobasic AX column and eluted with 10mM Ammonium acetate and Acetonitrile: 60:40, v/v at a flow rate of 0.5mL/min. MRM transitions were monitored in negative mode as m/z 348.1 → 206.8 (AMP), 231.9 → 187.8 (SUL) and m/z 353.0 → 211.9 (AMP D5). Sample concentrations were calculated by linear regression analysis using the analyst software1.6.3. An excellent linear response was obtained over the concentration ranges 0.1040µg/mL to 10.1562µg/mL for Ampicillin and 0.0510µg/mL to 6.1552µg/mL for Sulbactam. The intra-day and inter-day precision were within 3.50% for all analytes. The assay accuracy was 96.27 –103.59 %. Mean recoveries were 84.51% and 98.54% for ampicillin and sulbactam, respectively. The limits of detections were 0.026µg/mL and 0.013µg/mL for ampicillin and sulbactam. This method was successfully used for a bioequivalence study.

Top

Keywords

Ampicillin, Sulbactam, Antibiotics, LCMS/MS, Validation.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
762,935,876 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.